In vitro activity of trovafloxacin against Chlamydia pneumoniae.

AUTOR(ES)

Roblin, P M

RESUMO

The in vitro susceptibilities of 12 strains of Chlamydia pneumoniae to a new quinolone, trovafloxacin, and ofloxacin, doxycycline, erythromycin, and azithromycin were determined. The activity of trovafloxacin was similar to that of ofloxacin, with a MIC at which 90% of the isolates are inhibited and a minimal concentration at which 90% of the isolates are killed of 1.0 microg/ml, but trovafloxacin was less active than doxycycline, erythromycin, and azithromycin.

Documentos Relacionados

• In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae.
• In vitro activities of five quinolones against Chlamydia pneumoniae.
• Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniae.
• In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae.
• In vitro activities of azithromycin and doxycycline against 15 isolates of Chlamydia pneumoniae.